1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial

BACKGROUND: Invasive aspergillosis (IA) is a life-threatening disease with limited treatment options and is associated with delays in effective treatment and significant early mortality. Posaconazole (POS) is a broad-spectrum triazole antifungal, that exhibits potent activity against yeasts and mold...

Descripción completa

Detalles Bibliográficos
Autores principales: Castanheira, Mariana, Woosley, Leah, Motyl, Mary, Han, Seongah, Campbell, Havilland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777633/
http://dx.doi.org/10.1093/ofid/ofaa439.1355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777633/
http://dx.doi.org/10.1093/ofid/ofaa439.1355

Ejemplares similares